PLAUR and neoplasm: In fact, several author recently suggested that the crosstalk between MCs and other tumor-infiltrating cells could be a potential target for anticancer therapies [13], or it is conceivable that agents acting on uPAR-mediated chemotaxis (i.e., by blocking the chemotactic epitope) may be used to modify the MCs driven inflammatory and tumor promoting reactions.